Katerina Savelieva is an accomplished scientific and business development manager with 10+ years of senior level interna...
KATERINA SAVELIEVA, PH.D. The Woodlands, TX 77381 Phone: 832-877-0697/E-mail:
[email protected] Alliance & Project Management • Marketing & Business Development • Outsourcing & Contract Research Business Planning & Operational Strategy • Key Accounts Management • Contract Negotiation & Administration Research & Development • Cross-functional Team Leadership • Corporate/Financial Review • Market Intelligence
PROFILE Accomplished scientific and business development leader with 10+ years of senior level international R&D and business development experience (4+ years in contract research). Decisive, highly effective leader with exceptional relationship management and team building skills, and proven success delivering multiple complex projects on schedule, within or under budget. Looking for a challenging position in Houston Oil & Gas/Energy industry sector to utilize strategic management, business development and marketing skills. SUMMARY OF ACCOMPLISHMENTS o o o o o o o
Directed research and development of leading edge neurological drugs Accomplished marketing manager: expanded client leads list by over 500% Skilled negotiator responsible for facilitating and managing $86M inter-company partnership Demonstrated fiscal acuity: increased revenue in corporate contract sales, reduced capital expenditures, completed multiple projects under budget Developed business opportunities with industry groups and universities Oversaw group budget, hiring and promoting of staff, established group training programs Bilingual: English, Russian
PROFESSIONAL EXPERIENCE PsychoGenics Inc. Tarrytown, NY 2010 – present Director of External Scientific Affairs (remote, based in Texas) PsychoGenics has operated as a contract research organization and a drug discovery company since 1999 and is a leader in a high throughput drug discovery where it has developed proprietary technologies. I was hired to generate new service business by identifying new clients and developing relationships with key research leaders, to establish and maintain client database and to assist with marketing efforts. Within a year I have achieved the following milestones: o Successfully negotiated and executed 30+ contracts with several large pharma companies, including Genentech, Janssen, BMS, Merck, Regeneron, Sanofi, and with numerous biotech clients o Secured repeat business from multiple new and existing clients o Saved more than 80% on capital equipment purchase costs o Selected universities interested in establishing PGI services on campus, two of which are in advanced stages of negotiations o Identified CROs for potential acquisition or partnerships; two partnering referral agreements signed o Expanded client leads list from ~400 clients in 2010 to over 2800 currently o Increased company revenue from 2011 in corporate contract sales, achieving 120% versus BOD o Created client database and managed all electronic marketing efforts o Designed marketing materials in collaboration with company’s corporate development o Wrote grants (SBIR, NIH, DOD) and prepared abstracts and posters for conferences o Responsible for preparing study plans and cost quotations, negotiating financial terms, reviewing reports, and helping clients understand the findings
Katerina Savelieva, Ph.D. o o
Page 2
Recommended new services, and directions for the service business and heightened PGI’s exposure through marketing, conferences, and road shows Identified M&A opportunities worldwide to expand service business
External Pharma Inc. The Woodlands, TX 2009 – 2010 President and Founder o Created preclinical neuroscience contract research organization, focusing on behavioral pharmacology, preclinical toxicology, and phenotyping (pre-seed development stage) o Did not obtain necessary funding to start operations Lexicon Pharmaceuticals, Inc. The Woodlands, TX 2002 –2009 Senior Scientific Group Leader, Neuroscience Research Lexicon is a biopharmaceutical company focused on drug discovery and development. The company is discovering and developing breakthrough treatments for human disease based on understanding genes function. I was hired to setup from scratch a behavioral pharmacology high-throughput testing facility and establish a team of associates and scientists to support drug discovery and in vivo pharmacology efforts. In this capacity, I have hired, trained and managed an 8-member team, selected and oversaw internal drug discovery programs, negotiated and managed Lexicon-BMS Neuroscience alliance, oversaw group budget, equipment purchases, annual performance reviews and worked with leadership in all functional areas on the continuous development/improvement of business processes to support cross functional teams and to ensure that work is complete and managed appropriately. o Established (from 1 to 8 members) and managed the Behavioral Pharmacology Group o Designed and created state-of-the-art behavioral pharmacology testing facility, including set-up and benchmark validation of all assays o Managed Bristol Myers Squibb Alliance Collaboration as Lexicon’s Co-Chair of Behavioral Working Group and Chair for several “Project Teams,” requiring constant contact with other groups at Lexicon and BMS teams in order to ensure timely and smooth communications between the two partners; yielded >$86 million revenue o Led a team of scientists and associates in the research and development of neurological drugs: our compound, LX6171, was Lexicon’s first-in-man investigational compound, currently in phase 2 trials o Identified and initiated projects on multiple novel therapeutic targets o Characterized more than 3000 gene knockout strains and pharmacologically validated more than 30 novel drug targets o Developed and oversaw implementation of group training programs, safety protocols and standard operating procedures (SOPs) o Submitted IACUC protocols for all assays, and communicated directly with IACUC chair and members o Supported in vivo PK/PD studies by providing behavioral toxicology assessment of investigational compounds and worked together with DMPK and pathology groups in characterization of lead compounds o Supervised all experiments related to Behavioral Pharmacology in Neuroscience drug discovery programs, and performed initial training of direct reports in behavioral testing, safety requirements, and other methodologies o Prepared group budget, hired, evaluated and promoted staff Russian Academy of Medical Sciences Moscow, Russia Researcher, Institute of Human Morphology
1998 – 2000
Katerina Savelieva, Ph.D.
Page 3
As a researcher I was involved in a number of projects investigating the development of the central nervous system, including development of brain implants that alleviate the symptoms associated with dopamine loss in Parkinson’s disease. I also taught several courses to graduate and undergraduate students. PROFESSIONAL EXPERTISE o
o
o o o
Proficient in Microsoft Office, Adobe Photoshop, EndNote, SalesForce, MedTrack, JD Edwards, Creative Bistro (marketing tool), Google analytics, various graphical (GraphPad Prism, Sigma Plot) and statistical (Statistica for Windows, SPSS) software Accomplished writer of grant proposals, white papers, marketing brochures, newsletters, announcements, book chapters, manuscripts, conference abstracts, posters and platform slide presentations, patents, study reports, and IND applications Meticulous and skilled editor; served as reviewer and member of Editorial Board for several scientific journals Statistica Training Certificate from StatSoft (data management & advanced statistical data analysis), 2004 Listed as an inventor on several United States patents and patent applications
EDUCATION University of Texas at Austin, College of Pharmacy Austin, TX Postdoctoral Researcher, Department of Pharmacology/Toxicology
2000 – 2002
Moscow Lomonosov State University, School of Biology Moscow, Russia 1994 – 1998 Ph.D. in Biological Sciences, Pharmacology and Neuroscience emphasis Advisor: Prof. Emeritus Ashmarin I. P., Department Chair o Co-developed and co-conducted initial clinical trials of “Semax”, a cognitive enhancer currently sold in Russia and some EU countries as a drug to increase memory and attention, both in normal and pathological conditions Moscow Lomonosov State University, School of Biology Moscow, Russia M.Sc. in Biology/Physiology, summa cum laude
1989 – 1994
AWARDS AND HONORS SFN, Women in Neuroscience and Eli Lilly Travel Award, 2001 FASEB Travel Award, 2001 Russian Academy of Sciences Fellowship for Young Researchers, 1998-2000 George Soros International Science Foundation Fellowship, 1996-1997 Gold Medal Award for Academic Excellence, Moscow Lomonosov State University, 1994 PROFESSIONAL AFFILIATIONS Society for Neuroscience (SFN) Member since 2000 International Behavioral Neuroscience Society (IBNS) Member since 1998 (Chair of IBNS’s Education and Training Committee, 2007-2009)
